Patents Assigned to NINGXIA EPPEN BIOTECH CO., LTD
  • Publication number: 20240076701
    Abstract: Provided are a recombinant strain with modified gene BBD29_14900, and a method for constructing the same and use thereof, with the production of L-glutamic acid as a specific application. Further provided is a method for introducing a point mutation into the BBD29_14900 gene coding sequence in Corynebacterium or improving the expression thereof. The method can cause a bacterial strain with the mutation to increase the fermentation yield of glutamic acid. The point mutation involves a mutation of the base at position 1114 in the sequence of the BBD29_14900 gene from guanine (G) to adenine (A), and thus a substitution of aspartic acid at position 372 in the coded corresponding amino acid sequence with asparagine.
    Type: Application
    Filed: December 29, 2022
    Publication date: March 7, 2024
    Applicant: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Fengyong MA, Aiying WEI, Gang MENG, Chunguang ZHAO, Huiping JIA, Houbo SU, Lipeng YANG, Xiaowei GUO, Bin TIAN, Xiaoqun ZHOU
  • Publication number: 20240067998
    Abstract: Disclosed are strain having enhanced L-glutamic acid production capacity, and method for constructing the same and use thereof. A nucleotide sequence is provided by introducing a point mutation to a wild-type BBD29-00405 gene in Corynebacterium glutamicum so that the base at position 597 of SEQ ID NO: 1 is mutated from guanine (G) into adenine (A). Also provided is a recombinant strain obtained by introducing the polynucleotide sequence into L-glutamic acid-producing Corynebacterium glutamicum, the recombinant strain comprising a BBD29-00405 gene containing a point mutation. Compared with an unmodified strain, the resulting strain facilitates production of L-glutamic acid at a higher concentration.
    Type: Application
    Filed: December 29, 2021
    Publication date: February 29, 2024
    Applicant: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Houbo SU, Aiying WEI, Gang MENG, Lipeng YANG, Fengyong MA, Huiping JIA, Xiaoqun ZHOU, Chunguang ZHAO
  • Publication number: 20240067999
    Abstract: A recombinant strain with modified gene BBD29_11265 and a method for constructing the same are provided. The recombinant strain is a bacterium that generates L-glutamic acid, and has an improved expression of a polynucleotide encoding an amino acid sequence of SEQ ID NO: 3 or a homologous sequence thereof; the improved expression can be having a point mutation in, and an enhanced expression of the polynucleotide encoding an amino acid sequence of SEQ ID NO: 3 or a homologous sequence thereof. A genetically engineered bacterium in which the base at position 70 in the BBD29_112665 gene sequence is mutated to adenine from guanine, causing alanine at position 24 in the coded corresponding amino acid sequence to be substituted with threonine, and an engineered bacterium overexpressing the BBD29_112665 gene or BBD29_11265G70A gene are constructed in the present invention, facilitating an increase in the production and conversion rate of L-glutamic acid.
    Type: Application
    Filed: December 28, 2021
    Publication date: February 29, 2024
    Applicant: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Aiying WEI, Gang MENG, Chunguang ZHAO, Huiping JIA, Houbo SU, Lipeng YANG, Xiaowei GUO, Bin TIAN, Fengyong MA, Xiaoqun ZHOU
  • Patent number: 11905540
    Abstract: A method for producing L-lysine by fermentation, comprising modifying a gene for coding an NCBI reference sequence NP_601029.1 and/or NP_599350.1 on a Corynebacterium bacterial chromosome to enable the activity and/or expression quantity of NP_601029.1 and/or NP_599350.1 to be reduced; replacing a promoter of one or more genes on the Corynebacterium bacterial chromosome with a EP5 promoter, and fermenting bacteria obtained by modification to produce L-lysine. Also provided are methods and applications derived from the method, and bacteria and promoter that can used in the methods and the applications.
    Type: Grant
    Filed: December 21, 2021
    Date of Patent: February 20, 2024
    Assignee: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Gang Meng, Aiying Wei, Fengyong Ma, Huiping Jia, Jiyin Ma
  • Patent number: 11242545
    Abstract: A method for producing L-lysine by fermentation, comprising modifying a gene for coding an NCBI reference sequence NP_601029.1 and/or NP_599350.1 on a Corynebacterium bacterial chromosome to enable the activity and/or expression quantity of NP_601029.1 and/or NP_599350.1 to be reduced; replacing a promoter of one or more genes on the Corynebacterium bacterial chromosome with a EP5 promoter, and fermenting bacteria obtained by modification to produce L-lysine. Also provided are methods and applications derived from the method, and bacteria and promoter that can used in the methods and the applications.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: February 8, 2022
    Assignee: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Gang Meng, Aiying Wei, Fengyong Ma, Huiping Jia, Jiyin Ma
  • Publication number: 20190322995
    Abstract: A method for fermentation-production of a pentanediamine, comprising: culturing a cell expressing a lysine decarboxylase to obtain a whole cell fermentation broth comprising a pentanediamine; and extracting the pentanediamine from the whole cell fermentation broth, and striping the whole cell fermentation broth of carbon dioxide contained therein before adding a strong base. The method greatly increases a production volume of the pentanediamine.
    Type: Application
    Filed: May 16, 2017
    Publication date: October 24, 2019
    Applicant: Ningxia EPPEN Biotech Co., Ltd
    Inventors: Jiyin MA, Tingyi WEN, Shuwen LIU, Yong LIANG, Daihuan LI, Yun ZHANG, Xiuling SHANG, Chunguang ZHAO, Xiaowei GUO, Gang MENG
  • Patent number: 10017798
    Abstract: The present invention discloses an E. coli engineering bacteria producing 1,5pentanediamine through a whole cell catalysis and its application. The engineering bacteria according to the present invention, is Escherichia coli (E. coli) strain B or its derivative strains with the overexpression of a lysine decarboxylase gene and a proper expression of a lysinecadaverine antiporter gene cadB.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: July 10, 2018
    Assignee: NINGXIA EPPEN BIOTECH CO., LTD
    Inventors: Tingyi Wen, Shuwen Liu, Yong Liang, Xiuling Shang, Qian Liu, Jifu Wen, Yun Zhang